Intensity-modulated radiation therapy for anal cancer
Publication
, Journal Article
Czito, BG; Pepek, JM; Meyer, JJ; Yoo, S; Willett, CG
Published in: ONCOLOGY
November 15, 2009
The contemporary treatment of anal cancer is combined-modality therapy with radiation therapy, fluorouracil, and mitomycin. This therapy results in long-term disease-free survival and sphincter preservation in the majority of patients. Tempering these positive results is the high rate of treatment-related morbidity associated with chemoradiation therapy for anal cancer. The use of intensity-modulated radiation therapy (IMRT) has the potential to reduce acute and chronic treatment-related toxicity, minimize treatment breaks, and potentially improve disease-related outcomes by permitting radiation dose escalation in selected cases.
Duke Scholars
Published In
ONCOLOGY
EISSN
0890-9091
ISSN
0890-9091
Publication Date
November 15, 2009
Volume
23
Issue
12
Citation
APA
Chicago
ICMJE
MLA
NLM
Czito, B. G., Pepek, J. M., Meyer, J. J., Yoo, S., & Willett, C. G. (2009). Intensity-modulated radiation therapy for anal cancer. ONCOLOGY, 23(12).
Czito, B. G., J. M. Pepek, J. J. Meyer, S. Yoo, and C. G. Willett. “Intensity-modulated radiation therapy for anal cancer.” ONCOLOGY 23, no. 12 (November 15, 2009).
Czito BG, Pepek JM, Meyer JJ, Yoo S, Willett CG. Intensity-modulated radiation therapy for anal cancer. ONCOLOGY. 2009 Nov 15;23(12).
Czito, B. G., et al. “Intensity-modulated radiation therapy for anal cancer.” ONCOLOGY, vol. 23, no. 12, Nov. 2009.
Czito BG, Pepek JM, Meyer JJ, Yoo S, Willett CG. Intensity-modulated radiation therapy for anal cancer. ONCOLOGY. 2009 Nov 15;23(12).
Published In
ONCOLOGY
EISSN
0890-9091
ISSN
0890-9091
Publication Date
November 15, 2009
Volume
23
Issue
12